Annual Interest Expense
N/A
December 1, 2024
Summary
- ABBV annual interest expense is not available.
Performance
ABBV Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Interest Expense
N/A
December 1, 2024
Summary
- ABBV quarterly interest expense is not available.
Performance
ABBV Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM Interest Expense
N/A
December 1, 2024
Summary
- ABBV TTM interest expense is not available.
Performance
ABBV TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Interest Expense Formula
Interest Expense = Carrying Value of Debt X Effective Interest Rate
ABBV Interest Expense Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
ABBV Interest Expense Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time |
AbbVie Interest Expense History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $720.00 M(-0.8%) | $2.67 B(+6.6%) |
| Jun 2024 | - | $726.00 M(+10.0%) | $2.50 B(+7.5%) |
| Mar 2024 | - | $660.00 M(+17.0%) | $2.33 B(+4.8%) |
| Dec 2023 | $2.22 B(-0.3%) | $564.00 M(+1.6%) | $2.22 B(-0.1%) |
| Sep 2023 | - | $555.00 M(+0.5%) | $2.23 B(-0.2%) |
| Jun 2023 | - | $552.00 M(-0.2%) | $2.23 B(-0.2%) |
| Mar 2023 | - | $553.00 M(-2.3%) | $2.23 B(+0.2%) |
| Dec 2022 | $2.23 B(-8.0%) | $566.00 M(+1.1%) | $2.23 B(-0.6%) |
| Sep 2022 | - | $560.00 M(+0.7%) | $2.24 B(-1.6%) |
| Jun 2022 | - | $556.00 M(+1.5%) | $2.28 B(-2.5%) |
| Mar 2022 | - | $548.00 M(-5.5%) | $2.34 B(-3.5%) |
| Dec 2021 | $2.42 B(-1.3%) | $580.00 M(-2.7%) | $2.42 B(-2.0%) |
| Sep 2021 | - | $596.00 M(-3.1%) | $2.47 B(-1.4%) |
| Jun 2021 | - | $615.00 M(-2.7%) | $2.51 B(-0.7%) |
| Mar 2021 | - | $632.00 M(+0.5%) | $2.52 B(+2.8%) |
| Dec 2020 | $2.45 B(+37.6%) | $629.00 M(-0.2%) | $2.45 B(+2.9%) |
| Sep 2020 | - | $630.00 M(-0.3%) | $2.38 B(+6.7%) |
| Jun 2020 | - | $632.00 M(+12.3%) | $2.23 B(+14.0%) |
| Mar 2020 | - | $563.00 M(+0.7%) | $1.96 B(+9.9%) |
| Dec 2019 | $1.78 B(+32.3%) | $559.00 M(+16.5%) | $1.78 B(+11.2%) |
| Sep 2019 | - | $480.00 M(+34.1%) | $1.60 B(+9.6%) |
| Jun 2019 | - | $358.00 M(-7.5%) | $1.46 B(+2.7%) |
| Mar 2019 | - | $387.00 M(+1.8%) | $1.43 B(+5.8%) |
| Dec 2018 | $1.35 B | $380.00 M(+12.1%) | $1.35 B(+6.4%) |
| Sep 2018 | - | $339.00 M(+5.9%) | $1.27 B(+3.8%) |
| Jun 2018 | - | $320.00 M(+3.6%) | $1.22 B(+3.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2018 | - | $309.00 M(+3.3%) | $1.19 B(+3.1%) |
| Dec 2017 | $1.15 B(+9.8%) | $299.00 M(+2.0%) | $1.15 B(-1.5%) |
| Sep 2017 | - | $293.00 M(+3.2%) | $1.17 B(+1.9%) |
| Jun 2017 | - | $284.00 M(+4.0%) | $1.14 B(+3.5%) |
| Mar 2017 | - | $273.00 M(-13.6%) | $1.10 B(+5.5%) |
| Dec 2016 | $1.05 B(+45.6%) | $316.00 M(+16.6%) | $1.05 B(+11.5%) |
| Sep 2016 | - | $271.00 M(+10.6%) | $939.00 M(+7.3%) |
| Jun 2016 | - | $245.00 M(+14.0%) | $875.00 M(+9.1%) |
| Mar 2016 | - | $215.00 M(+3.4%) | $802.00 M(+11.5%) |
| Dec 2015 | $719.00 M(+67.6%) | $208.00 M(+0.5%) | $719.00 M(+10.6%) |
| Sep 2015 | - | $207.00 M(+20.3%) | $650.00 M(+10.0%) |
| Jun 2015 | - | $172.00 M(+30.3%) | $591.00 M(+20.1%) |
| Mar 2015 | - | $132.00 M(-5.0%) | $492.00 M(+14.4%) |
| Dec 2014 | $429.00 M(+43.5%) | $139.00 M(-6.1%) | $430.00 M(+17.8%) |
| Sep 2014 | - | $148.00 M(+102.7%) | $365.00 M(+25.0%) |
| Jun 2014 | - | $73.00 M(+4.3%) | $292.00 M(-2.0%) |
| Mar 2014 | - | $70.00 M(-5.4%) | $298.00 M(-0.7%) |
| Dec 2013 | $299.00 M(+187.5%) | $74.00 M(-1.3%) | $300.00 M(-6.3%) |
| Sep 2013 | - | $75.00 M(-5.1%) | $320.00 M(+25.5%) |
| Jun 2013 | - | $79.00 M(+9.7%) | $255.00 M(+44.9%) |
| Mar 2013 | - | $72.00 M(-23.4%) | $176.00 M(+69.2%) |
| Dec 2012 | $104.00 M(>+9900.0%) | $94.00 M(+840.0%) | $104.00 M(+940.0%) |
| Sep 2012 | - | $10.00 M(>+9900.0%) | $10.00 M(>+9900.0%) |
| Jun 2012 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2012 | - | $0.00 | $0.00 |
| Dec 2011 | $0.00(0.0%) | - | - |
| Dec 2010 | $0.00 | - | - |
FAQ
- What is the all time high annual interest expense for AbbVie?
- What is the all time high quarterly interest expense for AbbVie?
- What is the all time high TTM interest expense for AbbVie?
What is the all time high annual interest expense for AbbVie?
AbbVie all-time high annual interest expense is $2.45 B
What is the all time high quarterly interest expense for AbbVie?
AbbVie all-time high quarterly interest expense is $726.00 M
What is the all time high TTM interest expense for AbbVie?
AbbVie all-time high TTM interest expense is $2.67 B